QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-neutral-on-minerva-neurosciences-lowers-price-target-to-4

HC Wainwright & Co. analyst Douglas Tsao maintains Minerva Neurosciences (NASDAQ:NERV) with a Neutral and lowers the pri...

 minerva-neurosciences-q3-eps-036-misses-035-estimate

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate ...

 minerva-stock-rises-after-securing-200m-for-schizophrenia-drug-trial

Minerva Neurosciences Inc (NASDAQ:NERV) shares are climbing Tuesday after the company announced up to $200 million in funding t...

 minerva-neurosciences-q2-eps-043-beats-090-estimate

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of...

 hc-wainwright--co-reiterates-neutral-on-minerva-neurosciences-maintains-5-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Minerva Neurosciences (NASDAQ:NERV) with a Neutral and maintains $5 ...

 minerva-neurosciences-q4-2024-gaap-eps-056-beats-105-estimate-cash-cash-equivalents-and-restricted-cash-at-december-31-2024-were-approximately-215m

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of...

 hc-wainwright--co-reiterates-neutral-on-minerva-neurosciences-maintains-5-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Minerva Neurosciences (NASDAQ:NERV) with a Neutral and maintains $5 ...

 minerva-neurosciences-q3-2024-gaap-eps-297-may-not-be-comparable-to-101-estimate

Minerva Neurosciences (NASDAQ:NERV) reported quarterly earnings of $2.97 per share which may not be comparable to analyst conse...

 hc-wainwright--co-maintains-neutral-on-minerva-neurosciences-lowers-price-target-to-5

HC Wainwright & Co. analyst Douglas Tsao maintains Minerva Neurosciences (NASDAQ:NERV) with a Neutral and lowers the pri...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION